Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy

Abstract

Biomimetic cell membrane-coated nanoparticles (CM-NPs) with superior biochemical properties have been broadly utilized for various biomedical applications. Currently, researchers primarily focus on using ultrasonic treatment and mechanical extrusion to improve the synthesis of CM-NPs. In this work, we demonstrate that microfluidic electroporation can effectively facilitate the synthesis of CM-NPs. To test it, FeO magnetic nanoparticles (MNs) and red blood cell membrane-derived vesicles (RBC-vesicles) are infused into a microfluidic device. When the mixture of MNs and RBC-vesicles flow through the electroporation zone, the electric pulses can effectively promote the entry of MNs into RBC-vesicles. After that, the resulting RBC membrane-capped MNs (RBC-MNs) are collected from the chip and injected into experimental animals to test the in vivo performance. Owing to the superior magnetic and photothermal properties of the MN cores and the long blood circulation characteristic of the RBC membrane shells, core-shell RBC-MNs were used for enhanced tumor magnetic resonance imaging (MRI) and photothermal therapy (PTT). Due to the completer cell membrane coating, RBC-MNs prepared by microfluidic electroporation strategy exhibit significantly better treatment effect than the one fabricated by conventional extrusion. We believe the combination of microfluidic electroporation and CM-NPs provides an insight into the synthesis of bioinpired nanoparticles to improve cancer diagnosis and therapy.

Microfluidics for Production of Particles: Mechanism, Methodology, and Applications

“…Copyright 2017, American Chemical Society. (d) Reproduced with permission . Copyright 2017, American Chemical Society.…”

Magnetic Mesoporous Silica Nanoparticles Cloaked by Red Blood Cell Membranes: Applications in Cancer Therapy

“…[18,19] Sometimes,alarge number of nanoparticles adheres around the blood vessels,w hich causes blood clots. [21][22][23][24][25][26][27][28][29] Recent studies report that cell membranes can be extracted and reconstructed on the surface of nanocarriers for biomedical applications. [21][22][23][24][25][26][27][28][29] Recent studies report that cell membranes can be extracted and reconstructed on the surface of nanocarriers for biomedical applications.…”

Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation

“…Initial work has relied on the co-extrusion of synthetic nanoparticles with cell membrane-derived vesicles through a nanoporous membrane. [68] The size, shape, surface charge, and the ratio of core nanoparticles to coating materials control the efficiency of cell membrane coating. [67] New approach is also seen in using electropolation to promote the fusion of the nanoparticles and cell membrane fragments when the mixture flows through a microfluidic channel.…”